Tiger Legatus Capital Management’s Tenet Healthcare THC Stock Holding History

Tiger Legatus Capital Management’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$13.9M	Buy	+162,000	New	+$13.3M	22.32%	2

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tiger Legatus Capital Management's THC Position: Q1 2022 in Review

Tiger Legatus Capital Management opened a new position in Tenet Healthcare (THC) in Q1 2022: 162,000 shares worth $13.9M. The stake represents 22.32% of the portfolio and ranks #2 among its holdings.

405 funds tracked by Wall St. Rank hold THC as of Q1 2022.

Tiger Legatus Capital Management held 162,000 shares of Tenet Healthcare worth $13.9M as of Q1 2022.
Tenet Healthcare was a new Tiger Legatus Capital Management position in Q1 2022.
Tenet Healthcare made up 22.32% of Tiger Legatus Capital Management's portfolio in Q1 2022, its #2 holding.
405 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Tiger Legatus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.